Orfao A - Search Results

1

Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside.

Caballero MD, González M, Cañizo MC, Orfao A, Nieto MJ, San Miguel JF. Caballero MD, et al. Among authors: orfao a. Leukemia. 1992 Aug;6(8):856-8. Leukemia. 1992. PMID: 1640739

2

Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.

Orfao A, Ciudad J, González M, San Miguel JF, García AR, López-Berges MC, Ramos F, Del Cañizo MC, Ríos A, Sanz M, et al. Orfao A, et al. Leukemia. 1992 Jan;6(1):47-51. Leukemia. 1992. PMID: 1736013

3

Prognostic value of immunological markers in acute myeloblastic leukemia.

San Miguel JF, Ojeda E, Gonzalez M, Orfao A, Cañizo MC, Sanchez J, Lopez-Borrasca A. San Miguel JF, et al. Among authors: orfao a. Leukemia. 1989 Feb;3(2):108-11. Leukemia. 1989. PMID: 2911203

4

Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.

Macedo A, Orfao A, Ciudad J, Gonzalez M, Vidriales B, Lopez-Berges MC, Martínez A, Landolfi C, Cañizo C, San Miguel JF. Macedo A, et al. Among authors: orfao a. Leukemia. 1995 Nov;9(11):1896-901. Leukemia. 1995. PMID: 7475281

5

Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia.

Vidriales MB, Orfao A, González M, Hernández JM, López-Berges MC, García MA, Cañizo MC, Caballero MD, Macedo A, Landolfi C, et al. Vidriales MB, et al. Among authors: orfao a. Leukemia. 1993 Dec;7(12):2026-9. Leukemia. 1993. PMID: 7504772

6

In vitro autonomous proliferation in ANLL: clinical and biological significance.

Almeida J, del Cañizo C, Orfao A, Hernandez J, Hernandez D, Galende J, Caballero D, Garcia-Sanz R, San Miguel JF. Almeida J, et al. Among authors: orfao a. Leuk Res. 1995 Jun;19(6):411-6. doi: 10.1016/0145-2126(95)00007-b. Leuk Res. 1995. PMID: 7596154

7

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.

Macedo A, Orfão A, Gonzalez M, Vidriales MB, López-Berges MC, Martínez A, San Miguel JF. Macedo A, et al. Among authors: orfao a. Leukemia. 1995 Jun;9(6):993-8. Leukemia. 1995. PMID: 7596191

8

Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry.

Orfao A, Ciudad J, Lopez-Berges MC, Lopez A, Vidriales B, Caballero MD, Valverde B, Gonzalez M, San Miguel JF. Orfao A, et al. Leuk Lymphoma. 1994;13 Suppl 1:87-90. doi: 10.3109/10428199409052682. Leuk Lymphoma. 1994. PMID: 8075587

9

Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis.

Escribano L, Ocqueteau M, Almeida J, Orfao A, San Miguel JF. Escribano L, et al. Among authors: orfao a. Leuk Lymphoma. 1998 Aug;30(5-6):459-66. doi: 10.3109/10428199809057558. Leuk Lymphoma. 1998. PMID: 9711908 Review.

10

An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia.

Martínez A, San Miguel JF, Vidriales MB, Ciudad J, Caballero MD, López-Berges MC, Moro MJ, Calmuntia MJ, Ortega F, Orfao A. Martínez A, et al. Among authors: orfao a. Cytometry. 1999 Apr 15;38(2):70-5. doi: 10.1002/(sici)1097-0320(19990415)38:2<70::aid-cyto4>3.0.co;2-s. Cytometry. 1999. PMID: 10323219 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters